Press Releases Lipum AB

Equities

Market Closed - Nasdaq Stockholm Other stock markets 15:45:38 07/06/2024 BST			5-day change	1st Jan Change
7.6 ^SEK	+4.83%		+10.95%	+16.56%

05-28	Lipum AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
05-06	Lipum Obtains SEK20 Million Loan from Flerie Invest	MT

Lipum: A new approach to chronic inflammation	05-29	AQ
Lipum Q1 - Initiating preparations for phase II	05-28	AQ
Lipum AB – interim report Q1 for the period January-March 2024	05-28	AQ
BioStock: Flerie Invest continues to support Lipum	05-13	AQ
Lipum receives loan commitment of SEK 20 million	05-06	AQ
BioStock: Lipum's CEO looks ahead after the rights issue	04-26	AQ
Lipum announces final outcome of the rights issue	04-25	AQ
Lipum - Financed and ready to go	04-24	AQ
Lipum announces preliminary outcome of the rights issue	04-23	AQ
Lipum and NorthX Biologics enter into new strategic manufacturing alliance	04-18	AQ
Lipum has been granted funding from Swelife	04-12	AQ
Lipum publishes supplement to the prospectus regarding the rights issue	04-05	AQ
Lipum publishes prospectus regarding the rights issue	04-03	AQ
BioStock: Lipum seeks patent protecting inflammation-driven cancer treatment	04-03	AQ
Lipum AB - Report from the Extraordinary General Meeting	04-02	AQ
Lipum strengthens its protection of the drug candidate SOL-116 through a patent application for inflammation-driven cancer	04-02	AQ
BioStock: Lipum has included first RA patient	03-22	AQ
Statement from the Board of Directors of Lipum regarding the mandatory public offer from Flerie Invest AB	03-20	AQ
LIPUM REPORTS FIRST PATIENT INCLUDED IN THE ONGOING PHASE I CLINICAL STUDY WITH SOL-116	03-19	AQ
BioStock: Lipum advances to phase II with capital raise, moves production to Sweden	03-12	AQ

No results for this search